The Regulation of Curcumin on the Amyloidogentic Pathaway of APP in Alzheimers Disease

张红梅,张雄,李昱
DOI: https://doi.org/10.3321/j.issn:1001-1978.2009.03.021
2009-01-01
Abstract:Aim To investigate the effects of Curcumin on the APP processing in the amyloidogenic pathway in vitro and explore its mechanisms on Aβ generation inhibition.Methods Plasmids APPswe and BACE1-mychis were transiently co-transfected in SH-SY5Y cell by LipofectaminTM2000.The cell line then treated with Curcumin at 0,1.25,5,20 μmol·L-1 for 24 h,or with Curcumin at 5 μmol·L-1 for 0,12,24 and 48 h for the time course assay.RT-PCR were performed to measure the endogenous levels of APP and BACE1 mRNA.Western blot were used to detect the protein expression of BACE1 and C99,the major β-secretase cleavage product.The concentration of Aβ40/42 was detected by β-amyloid 1~40 or 42 Colorimetric ELISA.Results RT-PCR results showed that the mRNA levels of APP and BACE1 were decreased obviously in a dose-and time-dependent manner after treated with Curcumin in SH-SY5Y(P0.05).Western Blotting results showed that the expression of BACE1 and C99 protein were all decreased in a dose-and time-dependent manner(P0.05).ELISA results showed that the generation of Aβ40/42 reduced significantly,also in a dose-and time-dependent manner(P0.05).Conclusion Our finding demonstrated that Curcumin could inhibit the expression of the APP at mRNA;the expression of the BACE1 at mRNA and protein levels,furthermore it could inhibit the generation of Aβ40/42,and those changes were dose-time dependent(P0.05).Those factors are key components in APP amyloidogenic pathway.
What problem does this paper attempt to address?